Przewlekła ciężka oporna na leczenie astma oskrzelowa

• Authors: Panaszek Bernard
• Languages of publication: PL

Keywords

PL

astma ciężka oporna na leczenie; unikalny patomechanizm; alternatywne próby leczenia; sposób; postępowania.

• Publisher: Stowarzyszenie Przyjaciół Medycyny Rodzinnej i Lekarzy Rodzinnych
• Journal: Family Medicine & Primary Care Review
• Year: 2012
• Issue: 2
• Pages: 270-275

Contributors

author

Panaszek Bernard

References

• Kuhl K, Hanania NA. Targeting IgE in asthma. Curr Opin Pulm Med 2012; 18: 1−5.
• Kroegel C. Global Initiative for Asthma (GINA) guidelines: 15 years of application. Expert Rev Clin Immunol 2009; 5:239−49.
• Małolepszy J. Therapeutic management in severe and difficult asthma in adults. Pol Merk Lek 2003; 14: 651−652.
• Barnes PJ. Severe asthma: advances in current management and future therapy. J Allergy Clin Immunol 2012; 129:48−59.
• Proceedings of the ATS workshop on refractory asthma: current understanding, recommendations, and unanswered questions. American Thoracic Society. Am J Respir Crit Care Med 2000; 162: 2341−2351.
• Chung KF. Inflammatory biomarkers in severe asthma. Curr Opin Pulm Med 2012; 18: 35−41.
• Pakhale S, Mulpuru S, Boyd M. Optimal management of severe/refractory asthma. Clin Med Insight Corc Respir Pulm Med 2011; 5(37): 47.
• Zureik M, Neukirch C, Leynaert B, et al. Sensitisation to airborne moulds and severity of asthma: cross sectional study from European Community respiratory health survey. BMJ 2002; 325: 411−414.
• Kowalski ML, Cieślak M, Pérez-Novo CA, et al. Clinical and immunological determinants of severe/refractory asthma (SRA): association with Staphylococcal superantigen-specific IgE antibodies. Allergy 2011; 66(1): 32−38. Doi:10.1111/j.1398-9995.2010.02379.x.
• Bateman ED, Hurd SS, Barnes PJ, et al. Global strategy for asthma management and prevention: GINA executive summary.Eur Respir J 2008; 31: 143−178
• II Katedra Chorób Wewnętrznych CM UJ. Astma ciężka i trudna. Zasady systemu opieki medycznej dla chorych na astmę oskrzelową o ciężkim przebiegu. Kraków: II Katedra Chorób Wewnętrznych CM UJ; 2003: 5−6.
• Panaszek B. Dysfunkcja strun głosowych i jej związek za astmą. Alergia 2007; 2: 9−12.
• Goldstein R, Bright J, Jones SM, et al. Severe vocal cord dysfunction resistant to all current therapeutic interventions.Respir Med 2007;101: 857−858.
• Lavoie KL, Bacon SL, Barone S, et al. What is worse for asthma control and quality of life: depressive disorders, anxiety disorders, or both? Chest 2006; 130: 1039−1047.
• Sciurba FC. Physiologic similarities and differences between COPD and asthma. Chest 2004; 126: 117−124.
• Panaszek B. Przewlekły obturacyjny zespół nakładania, współwystępowanie astmy i POChP. Fam Med Prim Care Rev 2010; 12: 9−14.
• Peters SP, Kunselman SJ, Icitovic N, et al. Tiotropium bromide step-up therapy for adults with uncontrolled asthma. N Engl J Med 2010; 363: 1715−1726.
• Morjaria JB, Polosa R. Recommendation for optimal management of severe refractory asthma. J Asthma Allergy 2010;3: 43−56.
• Busse W, Corren J, Lanier BQ, et al. Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma. J Allergy Clin Immunol 2001; 108: 184−190.
• Simpson JL, Powell H, Boyle MJ, et al. Clarithromycin targets neutrophilic airway inflammation in refractory asthma.Am J Respir Crit Care Med 2008; 177: 148−155.
• Denning DW, O’Driscoll BR, Powell G, et al. Randomized controlled trial of oral antifungal treatment for severe asthma with fungal sensitization: the Fungal Asthma Sensitization Trial (FAST) study. Am J Respir Crit Care Med 2009;179: 11−18.
• Wenzel SE, Barnes PJ, Bleecker ER, et al. A randomized, double-blind, placebo-controlled study of tumor necrosis factor-alpha blockade in severe persistent asthma. Am J Respir Crit Care Med 2009; 179: 549−558.
• Castro M, Rubin AS, Laviolette M, et al. Effectiveness and safety of bronchial thermoplasty in the treatment of severe asthma: a multicenter, randomized, double-blind, sham-controlled clinical trial. Am J Respir Crit Care Med 2010; 181:116−124.